Impact of prior rituximab on outcomes of autologous stem-cell transplantation in patients with relapsed or refractory aggressive B-cell lymphoma: A multicentre retrospective Spanish group of lymphoma/autologous bone marrow transplant study

British Journal of Haematology

Volumn 164, Issue 5, 2014, Pages 668-674

  Redondo, Alba M ^a   Pomares, Helena ^b   Vidal, María J ^c   Pascual, María J ^d   Quereda, Belén ^e   Sancho, Juan M ^f   Polo, Marta ^g   López, Javier ^h   Conde, Eulogio ⁱ   Jarque, Isidro ^j   Alonso, Natalia ^k   Ramírez, María J ^l   Fernández, Pascual ^m   Sayas, María J ⁿ   Requena, María J ^o   Salar, Antonio ^p   González, José D ^q   González Barca, Eva ^b   Arranz, Reyes ^e   Caballero, Dolores ^a   Martín, Alejandro ^a   more..

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL DONOSTIA   (Spain)

^d HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^e HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^f HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^g HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^h HOSPITAL RAMÓN Y CAJAL   (Spain)

ⁱ HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^j HOSPITAL UNIVERSITARIO LA FE   (Spain)

^k University Hospital of Santiago de Compostela   (Spain)

^l HOSPITAL DE JEREZ   (Spain)

^m HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

ⁿ HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^o HOSPITAL SEVERO OCHOA   (Spain)

^p HOSPITAL DEL MAR   (Spain)

^q HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

more..

Author keywords

Aggressive B cell lymphoma; Autologous stem cell transplantation; Diffuse large B cell lymphoma; Rituximab; Salvage therapy

Indexed keywords

AGGRESSIVE B-CELL LYMPHOMA; AUTOLOGOUS STEM-CELL TRANSPLANTATION; DIFFUSE LARGE B-CELL LYMPHOMA; RITUXIMAB; SALVAGE THERAPY;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; FEMALE; GRAFT SURVIVAL; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84894042660     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12676     Document Type: Article

References (19)

1. Armand, P., Welch, S., Kim, H.T., LaCasce, A.S., Jacobsen, E.D., Davids, M.S., Jacobson, C., Fisher, D.C., Brown, J.R., Coughlin, E., Freedman, A.S. & Chen, Y.B. (2013) Prognostic factors for patients with diffuse large B cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the positron emission tomography era. British Journal of Haematology, 160, 608-617.
2. Caballero, M.D., Pérez-Simón, J.A., Iriondo, A., Lahuerta, J.J., Sierra, J., Marín, J., Gandarillas, M., Arranz, R., Zuazu, J., Rubio, V., Fernández de Sevilla, A., Carreras, E., García-Conde, J., García-Laraña, J., Grande, C., Sureda, A., Vidal, M.J., Rifón, J., Pérez-Equiza, C., Varela, R., Moraleda, J.M., García Ruíz, J.C., Albó, C., Cabrera, R. & San Miguel, J.F. (2003) High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group. Annals of Oncology, 14, 140-151.
3. Campo, E., Swerdlow, S.H., Harris, N.L., Pileri, S., Stein, H. & Jaffe, E.S. (2011) The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood, 117, 5019-5032.
4. Cheson, B.D., Horning, S.J., Coiffier, B., Shipp, M.A., Fisher, R.I., Connors, J.M., Andrew Lister, T., Vose, J., Grillo-López, A., Hagenbeek, A., Cabanillas, F., Klippensten, D., Hiddemann, W., Castellino, R., Harris, N.L., Armitage, J.O., Carter, W., Hoppe, R. & Canellos, G.P. (1999) Report of an international workshop to standardize response criteria for Non-Hodgkin's lymphomas. Journal of Clinical Oncology, 17, 1244.
5. Coiffier, B., Lepage, E., Brière, J., Herbrecht, R., Tilly, H., Bouabdallah, R., Morel, P., Van Den Neste, E., Salles, G., Gaulard, P., Reyes, F., Lederlin, P., Lederlin, P. & Gisselbrecht, C. (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. New England Journal of Medicine, 346, 235-242.
6. Derenzini, E., Musuraca, G., Fanti, S., Stefoni, V., Tani, M., Alinari, L., Venturini, F., Gandolfi, L., Baccarani, M. & Zinzani, P.L. (2008) Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma. Cancer, 113, 2496-2503.
7. Fenske, T.S., Hari, P.N., Carreras, J., Zhang, M.-J., Kamble, R.T., Bolwell, B.J., Cairo, M.S., Champlin, R.E., Chen, Y.B., Freytes, C.O., Gale, R.P., Hale, G.A., Ilhan, O., Khoury, J., Lister, J., Maharaj, D., Marks, D.I., Munker, R., Pecora, A.L., Rowlings, P.A., Shea, T.C., Stiff, P., Wiernik, P.H., Winter, J.N., Rizzo, J.D., Besien, K., Lazarus, H.M. & Vose, J.M. (2009) Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma. Biology of Blood and Marrow Transplantation, 15, 1455-1464.
8. Gisselbrecht, C., Glass, B., Mounier, N., Singh Gill, D., Linch, D.C., Trneny, M., Bosly, A., Ketterer, N., Shpilberg, O., Hagberg, H., Ma, D., Brière, J., Moskowitz, C.H. & Schmitz, N. (2010) salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era. Journal of Clinical Oncology, 28, 4184-4190.
9. Maloney, D.G. (2012) Anti-CD20 antibody therapy for B-cell lymphomas. New England Journal of Medicine, 366, 2008-2016.
10. Martín, A., Conde, E., Arnan, M., Canales, M.A., Deben, G., Sancho, J.M., Andreu, R., Salar, A., García-Sanchez, P., Vázquez, L., Nistal, S., Requena, M.J., Donato, E.M., González, J.A., León, A., Ruiz, C., Grande, C., González-Barca, E. & Caballero, M.D.; Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea (GEL/TAMO Cooperative Group). (2008). R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study. Haematologica 93: 1829-1836.
11. Moore, S., Peggs, K., Thomson, K., Lowry, L., Ljubic, A., Goldstone, A.H., Linch, D.C. & Ardeshna, K.M. (2012) Autologous stem cell transplantation remains beneficial for patients relapsing after R-CHOP chemotherapy and who respond to salvage chemotherapy. British Journal of Haematology, 156, 142-143.
12. Mounier, N., Canals, C., Gisselbrecht, C., Cornelissen, J., Foa, R., Conde, E., Maertens, J., Attal, M., Rambaldi, A., Crawley, C., Luan, J.J., Brune, M., Wittnebel, S., Cook, G., van Imhoff, G.W., Pfreundschuh, M., Sureda, A.; Lymphoma Working Party of European Blood and Marrow Transplantation Registry (EBMT). (2012) High-dose therapy and autologous stem cell transplantation in first relapse for diffuse large b cell lymphoma in the rituximab era: an analysis based on data from the European blood and marrow transplantation registry. Biology of Blood and Marrow Transplantation, 18, 788-793.
13. Oliansky, D.M., Czuczman, M., Fisher, R.I., Irwin, F.D., Lazarus, H.M., Omel, J., Vose, J., Wolff, S.N., Jones, R.B., McCarthy, P.L. Jr & Hahn, T. (2011) The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based review. Biology of Blood and Marrow Transplantation, 17, 18-19.
14. Pfreundschuh, M., Kuhnt, E., Trümper, L., Österborg, A., Trneny, M., Shepherd, L., Gill, D.S., Walewski, J., Pettengell, R., Jaeger, U., Zinzani, P.L., Shpilberg, O., Kvaloy, S., de Nully Brown, P., Stahel, R., Milpied, N., López-Guillermo, A., Poeschel, V., Grass, S., Loeffler, M. & Murawski, N.; MabThera International Trial (MInT) Group. (2011). CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group. The Lancet Oncology 12: 1013-1022.
15. Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van Der Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J.Y., Harousseau, J.L., Coiffier, B., Biron, P., Mandelli, F. & Chauvin, F. (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive Non-Hodgkin's lymphoma. New England Journal of Medicine, 333, 1540-1545.
16. Schot, B.W., Zijlstra, J.M., Sluiter, W.J., van Imhoff, G.W., Pruim, J., Vaalburg, W. & Vellenga, E. (2007) Early FDG-PET assessment in combination with clinical risk scores determines prognosis in recurring lymphoma. Blood, 109, 486-491.
17. Sehn, L.H., Berry, B., Chhanabhai, M., Fitzgerald, C., Gill, K., Hoskins, P., Klasa, R., Savage, K.J., Shenkier, T., Sutherland, J., Gascoyne, R.D. & Connors, J.M. (2007) The revised international prognostic index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. Blood, 109, 1857-1861.
18. Smith, S.D., Bolwell, B.J., Rybicki, L.A., Kang, T., Dean, R., Advani, A., Thakkar, S., Sobecks, R., Kalaycio, M., Pohlman, B. & Sweetenham, J.W. (2011) Comparison of outcomes after auto-SCT for patients with relapsed diffuse large B-cell lymphoma according to previous therapy with rituximab. Bone Marrow Transplantation, 46, 262-266.
19. Tarella, C., Zanni, M., Magni, M., Benedetti, F., Patti, C., Barbui, T., Pileri, A., Boccadoro, M., Ciceri, F., Gallamini, A., Cortelazzo, S., Majolino, I., Mirto, S., Corradini, P., Passera, R., Pizzolo, G., Gianni, A.M. & Rambaldi, A. (2008) Rituximab improves the efficacy of high-dose chemotherapy with autograft for high-risk follicular and diffuse large B-cell lymphoma: a multicenter gruppo italiano terapie innnovative nei linfomi survey. Journal of Clinical Oncology, 26, 3166-3175.